Renin-angiotensin system pathway therapeutics associated with improved outcomes in males hospitalized with COVID-19
GLY Rocheleau, T Lee, Y Mohammed… - Critical Care …, 2022 - journals.lww.com
OBJECTIVES: To determine whether angiotensin receptor blockers (ARBs) or angiotensin-
converting enzyme (ACE) inhibitors are associated with improved outcomes in hospitalized …
converting enzyme (ACE) inhibitors are associated with improved outcomes in hospitalized …
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
N Uaprasert, K Panrong, P Rojnuckarin, T Chiasakul - Thrombosis journal, 2021 - Springer
Background Thromboembolic and bleeding events after vaccination against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to …
Elevated ubiquitination contributes to protective immunity against severe SARS‐CoV‐2 infection
Y Che, D Jiang, Y Zhang, J Zhang, T Xu… - Clinical and …, 2022 - Wiley Online Library
Background The crosstalk between the ubiquitin‐proteasome and the immune system plays
an important role in the health and pathogenesis of viral infection. However, there have …
an important role in the health and pathogenesis of viral infection. However, there have …
Cytokine patterns in COVID-19 patients: Which cytokines predict mortality and which protect against?
M Basheer, E Saad, M Kananeh, L Asad… - Current Issues in …, 2022 - mdpi.com
(1) Background/Aim: People infected with SARS-CoV-2 may develop COVID-19 in a wide
range of clinical severity. Pulmonary fibrosis is characterized by several grades of chronic …
range of clinical severity. Pulmonary fibrosis is characterized by several grades of chronic …
COVID-19 infection after total joint arthroplasty is associated with increased complications
EM Forlenza, JDD Higgins, RA Burnett, J Serino… - The Journal of …, 2022 - Elsevier
Background The impact of a postoperative diagnosis of COVID-19 in patients undergoing
total joint arthroplasty (TJA) remains unknown. The objective of this study is to characterize …
total joint arthroplasty (TJA) remains unknown. The objective of this study is to characterize …
Risk factors for postdischarge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities: Insights from the CORE …
Background Coronavirus disease 2019 (COVID-19) is associated with venous and arterial
thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients …
thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients …
[HTML][HTML] Cardiovascular complications of COVID-19 severe acute respiratory syndrome
RJ Henning - American Journal of Cardiovascular Disease, 2022 - ncbi.nlm.nih.gov
Abstract 603,711,760 confirmed cases of COVID-19 have been reported throughout the
world and 6,484,136 individuals have died from complications of COVID-19 as of September …
world and 6,484,136 individuals have died from complications of COVID-19 as of September …
A COVID-19 patient with simultaneous renal infarct, splenic infarct and aortic thrombosis during the severe disease
G Mavraganis, S Ioannou, A Kallianos, G Rentziou… - Healthcare, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
associated with a high incidence of arterial and venous thrombotic complications. However …
associated with a high incidence of arterial and venous thrombotic complications. However …
Clinical predictors of mortality and critical illness in patients with covid-19 pneumonia
M Basheer, E Saad, R Hagai, N Assy - Metabolites, 2021 - mdpi.com
Early identification of patients with COVID-19 who will develop severe or critical disease
symptoms is important for delivering proper and early treatment. We analyzed demographic …
symptoms is important for delivering proper and early treatment. We analyzed demographic …
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
N Potere, M Candeloro, E Porreca, S Marinari… - Journal of Thrombosis …, 2022 - Springer
Direct oral anticoagulants (DOACs) are not recommended in COVID-19 patients receiving
dexamethasone because of potential drug-drug and drug-disease interactions affecting …
dexamethasone because of potential drug-drug and drug-disease interactions affecting …